Gene: NAALADL2
Official Full Name: N-acetylated alpha-linked acidic dipeptidase like 2provided by HGNC
Gene Summary: Predicted to act upstream of or within response to bacterium. Located in nucleoplasm. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO21136 | NAALADL2 Knockout cell line (HCT 116) | Human | NAALADL2 | 1:2~1:4 | Negative | Online Inquiry |
NAALADL2 Gene Knockout Cell Lines are expertly engineered cellular models that have been specifically designed to study the biological role of the NAALADL2 gene, also known as N-acetylated alpha-linked acidic dipeptidase-like 2. This gene is implicated in various neurological processes and diseases, making these cell lines invaluable for researchers focusing on neurobiology, cellular signaling, and potential therapeutic targets.
The key function of NAALADL2 involves its role in modulating cellular pathways that govern neuron development and homeostasis. By utilizing CRISPR-Cas9 gene editing technology, our knockout cell lines effectively disable NAALADL2 expression, allowing researchers to observe the resultant phenotypic and molecular changes. This perturbation facilitates studies into the gene’s involvement in neurodegenerative diseases and the mechanisms by which it influences neuronal health.
In the realm of scientific importance, these knockout cell lines serve as a robust tool for elucidating NAALADL2's function in neural tissue regeneration, synaptic transmission, and response to neurotoxic insults. Clinically, understanding these pathways can support the discovery of novel therapeutic strategies for conditions such as Alzheimer's disease and other cognitive impairments.
Compared to traditional models, our NAALADL2 gene knockout cell lines exemplify specificity and reproducibility, enabling unambiguous interpretation of data. The absence of the target gene significantly streamlines experimental processes, allowing for direct correlations between NAALADL2 activity and various cellular outcomes, addressing a critical need in biomedical research.
For researchers and clinicians, this product enhances experimental rigor by providing a clear platform for hypothesis testing and drug discovery, transforming insights into actionable therapeutic pathways. With our deep expertise in cell line development and gene editing, we are committed to delivering high-quality, validated products that empower scientific innovation and discovery.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.